Abstract
Recent successes achieved in the therapy of various types of cancer have in many instances been attributable to the cytotoxicity of new chemotherapeutic agents. Many of the drugs have been used effectively in hematologic neoplasms, and with their use, complete remission and survival rates in childhood leukemia and in Hodgkin’s disease and other lymphomas have increased very significantly. Several of the solid tumors such as sarcomas, breast carcinoma, and testicular cancer have demonstrated sensitivity to single agents and combinations of drugs. Unfortunately, in advanced and metastatic tumors, responses are short-lived, the tumors rapidly become resistant to the drugs, and the patient dies from uncontrollable disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bertino, J. G., Boston, B., AND Capizzi, R. L., 1975, The role of chemotherapy in the management of cancer of the head and neck, Cancer 36: 752–758.
Bonadonna, G., Brusamolino, E., Valagussa, P., et al., 1976, Combination chemotherapy as an adjuvant treatment in operable breast cancer, N. Engl. J. Med. 294:406–410.
Brunner, K. W., Marthaler, T. H., AND Muller, W., 1973, Effects of long term adjuvant chemotherapy with cyclophosphamide for radically resected bronchogenic carcinoma, Cancer Chemother. Rep. Part 3 4: 125–132.
Burchenal, J. H., 1976, Adjuvant therapy—theory, practice and potential, Cancer 37: 46–57.
Cole, W. H., Packard, D., AND Southwick, H. W., 1954, Carcinoma of the colon with special reference to prevention of recurrence, J. Amer. Med. Assoc. 155: 1549–1553.
Cortes, E. P., Holland, J. F., AND Wand, J. J., 1975, Adriamycin in primary osteosarcoma, Proc. Amer. Soc. Clin. Oncol. 16: 241 (abstract).
Cvitkovic, E., Hayes, D., AND Golbey, R., 1976, Primary combination chemotherapy (VAB III) for metastatic or unresectable germ cell tumors, Proc. Amer. Soc. Clin. Oncol. 17: 296 (abstract).
Delarue, N. C., 1960, The free cancer cell, Can. Med. Assoc. J. 82:1175-1183.
Donaldson, R. C., 1973, Chemoimmunotherapy for cancer of the head and neck, Amer. J. Surg. 126: 507–512.
Donaldson, S. S., Castro, J. R., Wilbur, J. R., AND Jesse, R. H., JR., 1973, Rhabdomyosarcoma of head and neck in children, Cancer 31: 26–35.
Farber, S., 1966, Chemotherapy in the treatment of leukemia and Wilms’s tumor, J. Amer. Med. Assoc. 198: 826–836.
Fernandez, C. H., Lindberg, R. D., Sutow, W. W., AND Samuels, M. L., 1974, Localized Ewing’s sarcoma—Treatment and results, Cancer 34: 143–148.
Finney, R., 1971, Adjuvant chemotherapy in the radical treatment of carcinoma of the breast—a clinical trial, Amer. J. Roentgenol. 111: 137–141.
Fisher, B., Ravdin, R. G., Ausman, R. K., et al.,1968, Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation, Ann. Surg. 168:337–356.
Fisher, B., Slack, N. H., Bross, I. D. J., et al.,1969, Cancer of the breast: Size of neoplasm and prognosis, Cancer 24:1071–1080.
Fisher, B., Nelson, M., Slack, N. H., Cavanaugh, P. J., Gardner, B., Ravdin, R. G., et al.,1970, Postoperative radiotherapy in the treatment of breast cancer, Ann. Surg. 172:711–732.
Fisher, B., Carbone, P., Economon, S. G., et al.,1975, L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings, N. Engl. J. Med. 292:117–122.
Freeman, A. I., Sachatello, C., Gaeta, J., et al.,1972, An analysis of Ewing’s tumor in children at Roswell Park Memorial Institute, Cancer 29:1563–1569.
Ghavimi, F., Tefft, M., AND Murphy, M. L., 1976, Further experience with multidisciplinary treatment of embryonal rhabdomyosarcoma, Proc. Amer. Soc. Clin. Oncol. 17: 307 (abstract).
Heyn, R. M., Holland, R., Newton, W. A., JR., et al.,1974, The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children, Cancer 34:2128–2141.
Hsutu, H. O., Pinkel, D., AND Pratt, C. B., 1972, Treatment of clinically localized Ewing’s sarcoma with radiotherapy and combination chemotherapy, Cancer 30: 1522–1527.
Jaffe, N., Frei, E., Traggis, D., AND Bihshop, Y., 1974, Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma, N. Engl. J. Med. 291: 994–997.
Johnson, R., AND Humphreys, S. R., 1969, Past failures and future possibilities in Ewing’s sarcoma: Experimental and preliminary clinical results, Cancer 23: 161–166.
Johnson, R. E., AND Pomeroy, T. C., 1975, Evaluation of therapeutic results in Ewing’s sarcoma, Amer. J. Roentgenol. 123: 583–587.
Kennedy, B. J., Mielke, P. W., AND Fortuny, I. E., 1964, Therapeutic castration versus prophylactic castration in breast cancer, Surg. Gynecol. Obstet. 118: 524–540.
Li, M. D., AND Ross, S. T., 1976, Chemoprophylaxis for patients with colorectal cancer. Prospective study with five-year follow-up, J. Amer. Med. Assoc. 235: 2825–2828.
Long, L., Jonasson, O., Roberts, S., Mcgrath, R., Mcgrew, E., AND Cole, W. H., 1960, Cancer cells in blood, Arch. Surg. 80: 910–917.
Long, R. L., Donegan, W. L., AND Evans, A. M., 1969, Extended surgical adjuvant chemotherapy for breast cancer, Amer. J. Surg. 117: 701–704.
Maier, J. G., 1970, Treatment of testicular germ cell malignancies, J. Amer. Med. Assoc. 213: 97–98.
Mcdonald, G. O., Livingstone, C., Boyles, C. F., AND Cole, W. H., 1957, The prophylactic treatment of malignant disease with nitrogen mustard and triethylenethiophosphoramide (Thiotepa), Ann. Surg. 145: 624–629.
Moertel, C. G., 1976, Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations, J. Amer. Med. Assoc. 235: 2135–2136.
Moore, G. E., AND Kondo, T., 1958, Study of adjuvant cancer chemotherapy b}% model experimentsSurgery 44:199-209.
Mrazek, R., 1970, Adjuvant chemotherapy with cancer of the breast at one institution, in: Chemotherapy of Cancer (W. H. Cole, ed.), pp. 289-292,Lee and Febiger, Philadelphia.
Muggia, F. M., 1974, Cell kinetic studies in patients with lung cancer, Oncology 30: 353–361.
Nissen-Meyer, R., 1973, Cyclophosphamide as adjuvant to the primary surgery for breast cancer—a cooperative controlled clinical trial, presented at the 8th International Congress of Chemotherapy, Athens, Sept. 8-14.
Nissen-Meyer, R., Kjellgren, K., AND Manson, B., 1971, Preliminary report from the Scandinavian Adjuvant Chemotherapy Study Group, Cancer Chemother. Rep. 55: 561–566.
Pomeroy, T. C., AND Johnson, R. E., 1975, Combined modality therapy of Ewing’s sarcoma, Cancer 35: 36–47.
Pratt, C. B., Hsutu, H. O., Fleming, D., AND Pinkel, D., 1972, Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy, Cancer Res. 32: 606–610.
Rieche, K., Berndt, H., AND Prohl, B., 1972, Continuous postoperative treatment with cyclophos- phamide in breast carcinoma—a randomized clinical study, Arch. Geschwulstforsch. 40: 349–354.
Rosen, G., Wollner, N., Tan, C., et al.,1974, Disease-free survival in children with Ewing’s sarcoma treated with radiation therapy and adjuvant four drug sequential chemotherapy, Cancer 33:384–393.
Rosen, G., Marcove, R., Beattie, E. J., et al.,1975a, Osteogenic sarcoma: Sequential chemotherapy in 45 consecutive patients, Proc. Amer. Soc. Clin. Oncol.15:227 (abstract).
Rosen, G., Mehta, B. M., Ghavimi, F., et al.,1975b, Intravenous high dose methotrexate with citrovorum factor “rescue.” CNS distribution and therapeutic response of intracranial neoplasms, Proc. Amer. Assoc. Cancer Res. 16:750 (abstract).
Salgado, I., Hopkirk, J. F., Long, R. C., Ritchie, A. C., Ritchie, S., AND Webster, D. R., 1959, Tumor cells in the blood, Can. Med. Assoc. J. 81: 619–622.
Samuels, M. L., Johnson, D. E., AND Holoye, P. Y., 1975, Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in Stage III testicular neoplasia, Cancer Chemother. Rep. 59: 563–570.
Schabel, F. M., 1975, Concepts for systemic treatment of micrometastases, Cancer 35: 15–24.
Selawry, O. S., 1974, The role of chemotherapy in the treatment of lung cancer, Semin. Oncol. 1: 259–272.
Shapiro, D. M., AND Fugmann, R. A., 1957, A role for chemotherapy as an adjunct to surgery, Cancer Res. 17: 1098–1101.
Smith, J. P., Rutledge, F. N., AND Delelos, L., 1975, Results of chemotherapy as an adjunct to surgery in patients with localized ovarian cancer, Semin. Oncol. 2: 277–281.
Sutow, W. W., 1965, Chemotherapy in childhood cancer—an appraisal, Cancer 18: 1585–1589.
Sutow, W. W., Sullivan, M. P., Fernbach, D. J., et al.,1975, Adjuvant chemotherapy in primary treatment of osteogenic sarcoma, Cancer 36:1598–1602.
Tormey, D. C., 1975, Combined chemotherapy and surgery in breast cancer: A review, Cancer 36: 881–892.
Walker, M. D., 1975, Chemotherapy: Adjuvant to surgery and radiation therapy, Semin. Oncol. 2: 69–72.
Wasserman, T. H., Comis, R. L., Goldsmith, M., et al.,1975, Tabular analysis of the clinical chemotherapy of solid tumors, Cancer Chemother. Rep. 6:399–419.
Wolff, J. A., 1975, Advances in the treatment of Wilms’s tumor, Cancer 35: 901–904.
Wolff, J. A., Krivit, W., Newton, W. A., JR., AND D’angio, G. J., 1968, Single versus multiple dose dactinomycin therapy of Wilms’s tumor—a controlled cooperative study conducted by the Chil- dren’s Cancer Study Group A, N. Engl. J. Med. 279: 290–299.
Wolff, J. A., D’angio, G. J., Hartmann, J., et al.,1974, Long term evaluation of single versus multiple courses of actinomycin-D therapy of Wilms’s tumor, N. Engl. J. Med. 290:84–86.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Shaw, M.T., Stebbins, R.D. (1977). Adjunctive Chemotherapy. In: Becker, F.F. (eds) Chemotherapy. Cancer, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6628-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6628-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6630-4
Online ISBN: 978-1-4615-6628-1
eBook Packages: Springer Book Archive